Study of Kusmanda Kshara in Helicobacter Pylori.

Clinical Evaluation on the Effect of Kusmanda Kshara in Acid Peptic Disease Caused by Helicobacter Pylori. - NIL

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/055613

Enrollment

Registered

2023-07-24

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K20-K31- Diseases of esophagus, stomach and duodenum

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects of age group between 20-60 years satisfying the diagnostic criteria irrespective of religion, caste, occupation and socioeconomic status. 2.Subjects with clinical signs and symptoms of Acid peptic disease caused by Helicobacter pylori, who have been selected by means of Helicobacter pylori Stool antigen test. 3.Subjects with classical symptoms of Shoola

Exclusion criteria

Exclusion criteria: 1.Subjects who are pregnant. 2.Subjects who are diagnosed with pyloric stenosis, stomach cancer.

Design outcomes

Primary

Measure	Time frame
Objective criteria Helicobacter pylori stool Antigen test and Subjective criteria epigastric pain,epigastric tenderness,heart burn,nausea and distension of abdomen.Timepoint: Objective criteria Helicobacter pylori stool Antigen test will be assessed before treatment & on 46th day Subjective criteria Like epigastric pain,epigastric tenderness,heart burn,nausea and distension of abdomen will be assessed before treatment on 46th day and on 61st day.	—

Measure

Time frame

Objective criteria Helicobacter pylori stool Antigen test and Subjective criteria epigastric pain,epigastric tenderness,heart burn,nausea and distension of abdomen.Timepoint: Objective criteria Helicobacter pylori stool Antigen test will be assessed before treatment & on 46th day Subjective criteria Like epigastric pain,epigastric tenderness,heart burn,nausea and distension of abdomen will be assessed before treatment on 46th day and on 61st day.

—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr N Madhuri Devi

Pankajakasthuri Ayurveda Medical College and PG center,Killy ,Kattakada,Thiruvananthapuram

Drsureshtriveni@gmail.com9447160480

Outcome results